NLRP3 |
Q96P20
|
NLR family pyrin domain containing 3
|
|
8.1E-04 |
0.361 |
0.962 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
CHD7 |
Q9P2D1
|
chromodomain helicase DNA binding protein 7
|
|
1.00 |
0.441 |
0.846 |
PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |
AHI1 |
Q8N157
|
Abelson helper integration site 1
|
|
1.1E-25 |
0.513 |
0.846 |
ATXN1 |
P54253
|
ataxin 1
|
|
0.97 |
0.534 |
0.769 |
JMJD1C |
Q15652
|
jumonji domain containing 1C
|
|
1.00 |
0.517 |
0.769 |
SH2B3 |
Q9UQQ2
|
SH2B adaptor protein 3
|
|
1.0E-04 |
0.527 |
0.692 |
PIGL |
Q9Y2B2
|
phosphatidylinositol glycan anchor biosynthesis class L
|
|
6.2E-09 |
0.581 |
0.731 |
PLAUR |
Q03405
|
plasminogen activator, urokinase receptor
|
|
5.3E-03 |
0.536 |
0.731 |
FADS2 |
O95864
|
fatty acid desaturase 2
|
|
1.00 |
0.575 |
0.692 |
GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |
RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |
FADS1 |
O60427
|
fatty acid desaturase 1
|
|
0.37 |
0.582 |
0.769 |
PNKD |
Q8N490
|
PNKD metallo-beta-lactamase domain containing
|
|
4.1E-08 |
0.615 |
0.615 |
ZMIZ1 |
Q9ULJ6
|
zinc finger MIZ-type containing 1
|
|
1.00 |
0.588 |
0.615 |
CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
TNFRSF10C |
O14798
|
TNF receptor superfamily member 10c
|
|
3.2E-06 |
0.578 |
0.731 |
GFI1B |
Q5VTD9
|
growth factor independent 1B transcriptional repressor
|
|
5.2E-04 |
0.623 |
0.500 |
CCDC26 |
Q8TAB7
|
CCDC26 long non-coding RNA
|
|
|
0.647 |
0.615 |
HECTD4 |
Q9Y4D8
|
HECT domain E3 ubiquitin protein ligase 4
|
|
1.00 |
0.700 |
0.462 |
TNS3 |
Q68CZ2
|
tensin 3
|
|
1.00 |
0.653 |
0.615 |
C11orf65 |
Q8NCR3
|
chromosome 11 open reading frame 65
|
|
2.0E-14 |
0.670 |
0.462 |